Show simple item record

dc.contributor.authorTuchina, Daria K.
dc.contributor.authorMeerovich, Irina G.
dc.contributor.authorSindeeva, Olga A.
dc.contributor.authorZherdeva, Victoria V.
dc.contributor.authorSavitsky, Alexander P.
dc.contributor.authorBogdanov, Alexei A. Jr.
dc.contributor.authorTuchin, Valery V.
dc.date2022-08-11T08:10:49.000
dc.date.accessioned2022-08-23T17:21:05Z
dc.date.available2022-08-23T17:21:05Z
dc.date.issued2020-07-20
dc.date.submitted2020-08-27
dc.identifier.citation<p>Tuchina DK, Meerovich IG, Sindeeva OA, Zherdeva VV, Savitsky AP, Bogdanov AA Jr, Tuchin VV. Magnetic resonance contrast agents in optical clearing: Prospects for multimodal tissue imaging. J Biophotonics. 2020 Jul 20:e201960249. doi: 10.1002/jbio.201960249. Epub ahead of print. PMID: 32687263. <a href="https://doi.org/10.1002/jbio.201960249">Link to article on publisher's site</a></p>
dc.identifier.issn1864-063X (Linking)
dc.identifier.doi10.1002/jbio.201960249
dc.identifier.pmid32687263
dc.identifier.urihttp://hdl.handle.net/20.500.14038/48445
dc.description.abstractSkin optical clearing effect ex vivo and in vivo was achieved by topical application of low molecular weight paramagnetic magnetic resonance contrast agents. This novel feature has not been explored before. By using collimated transmittance the diffusion coefficients of three clinically used magnetic resonance contrast agents, that is Gadovist, Magnevist and Dotarem as well as X-ray contrast agent Visipaque in mouse skin were determined ex vivo as (4.29 +/- 0.39) x 10(-7) cm(2) /s, (5.00 +/- 0.72) x 10(-7) cm(2) /s, (3.72 +/- 0.67) x 10(-7) cm(2) /s and (1.64 +/- 0.18) x 10(-7) cm(2) /s, respectively. The application of gadobutrol (Gadovist) resulted in efficient optical clearing that in general, was superior to other contrast agents tested and allowed to achieve: (a) more than 12-fold increase of transmittance over 10 minutes after application ex vivo; (b) markedly improved images of skin architecture obtained with optical coherence tomography; (c) an increase of the fluorescence intensity/background ratio in TagRFP-red fluorescent marker protein expressing tumor by five times after 15 minutes application into the skin in vivo. The obtained results have immediate implications for multimodality imaging because many contrast agents are capable of simultaneously enhancing the contrast of multiple imaging modalities.
dc.language.isoen_US
dc.relation<p><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&list_uids=32687263&dopt=Abstract">Link to Article in PubMed</a></p>
dc.relation.urlhttps://doi.org/10.1002/jbio.201960249
dc.subjectoptical clearing
dc.subjectMRI/CT contrast agents
dc.subjectmouse skin
dc.subjectdiffusion coefficients
dc.subjectOCT
dc.subjectfluorescence imaging
dc.subjectmultimodality
dc.subjectAnalytical, Diagnostic and Therapeutic Techniques and Equipment
dc.subjectBioimaging and Biomedical Optics
dc.subjectBiological and Chemical Physics
dc.subjectRadiology
dc.titleMagnetic resonance contrast agents in optical clearing: Prospects for multimodal tissue imaging
dc.typeJournal Article
dc.source.journaltitleJournal of biophotonics
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/radiology_pubs/551
dc.identifier.contextkey19164792
html.description.abstract<p>Skin optical clearing effect ex vivo and in vivo was achieved by topical application of low molecular weight paramagnetic magnetic resonance contrast agents. This novel feature has not been explored before. By using collimated transmittance the diffusion coefficients of three clinically used magnetic resonance contrast agents, that is Gadovist, Magnevist and Dotarem as well as X-ray contrast agent Visipaque in mouse skin were determined ex vivo as (4.29 +/- 0.39) x 10(-7) cm(2) /s, (5.00 +/- 0.72) x 10(-7) cm(2) /s, (3.72 +/- 0.67) x 10(-7) cm(2) /s and (1.64 +/- 0.18) x 10(-7) cm(2) /s, respectively. The application of gadobutrol (Gadovist) resulted in efficient optical clearing that in general, was superior to other contrast agents tested and allowed to achieve: (a) more than 12-fold increase of transmittance over 10 minutes after application ex vivo; (b) markedly improved images of skin architecture obtained with optical coherence tomography; (c) an increase of the fluorescence intensity/background ratio in TagRFP-red fluorescent marker protein expressing tumor by five times after 15 minutes application into the skin in vivo. The obtained results have immediate implications for multimodality imaging because many contrast agents are capable of simultaneously enhancing the contrast of multiple imaging modalities.</p>
dc.identifier.submissionpathradiology_pubs/551
dc.contributor.departmentDepartment of Radiology
dc.source.pagese201960249


This item appears in the following Collection(s)

Show simple item record